The authorization covers 2 mg/pen and 4 mg/pen presentations at 1.34 mg/mL, with launch preparations underway, Dr
they may recommend gradual dose escalation, alternative injection sites, or a different formulation to minimize itching
Patient Safety Continuing appetite-suppressing medication at very low BMIs may increase the risk of: Excessive or unintended weight loss Nutritional deficiencies Lean muscle loss Hormonal disruption Disordered eating patterns The BMI 22 kg/m threshold acts as a safety boundary
Murphy, M.P
Thats important because it expands the number of people who could benefit from the drug, says Tiffany Powell-Wiley, a cardiologist and epidemiologist at the National Heart, Lung and Blood Institute in Bethesda, Md
Increased Energy Production: Acetyl L-Carnitine aids in producing adenosine triphosphate (ATP), which is the main source of energy for the cells